Press Release
Category Added in a WPeMatico Campaign
-
Biozen Named Finalist in ACC 2026 Innovation Pitch Challenge
One of four companies selected to present at the American College of Cardiology Scientific Sessions in New Orleans OKLAHOMA CITY,…
Read More » -
Benzinga Expands Global Reach With Mirae Asset Securities Relationship to Deliver U.S. Market Intelligence to Korean Investors
DETROIT and SEOUL, South Korea , March 26, 2026 /PRNewswire/ — Benzinga, the largest financial news provider in North America,…
Read More » -
Freightos Executes Cost Optimization Plan to Support Path to Profitability
Actions align with previously communicated path to Adjusted EBITDA breakeven by the end of 2026 Continued investment in growth initiatives across…
Read More » -
Signal AI Acquires Memo to Bring First-Ever Real Readership Data into Reputation Intelligence
Signal AI is building the reputation and risk tech modern leaders need to navigate a volatile world LONDON and NEW…
Read More » -
Boehringer Ingelheim and Connecticut Science Center Launch an Innovation Lab to Advance STEM Education Across Connecticut
Expanding access to science programming and inspiring the next generation of scientists in Connecticut Innovation Lab ribbon cutting ceremony to…
Read More » -
Peritia Appoints Michael A. Griffith as Chief Executive Officer
Veteran life sciences executive and platform builder brings decades of biopharma leadership to accelerate growth. MORRISVILLE, N.C. and NEW YORK,…
Read More » -
BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
GLIX1, a TET2 activator, is a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other cancers GLIX1 has demonstrated…
Read More » -
Avoid Penalties When E-Filing W-2 and W-3 Corrections with ezW2Correction from Halfpricesoft.com.
Affordable, SSA-approved software helps businesses correct errors quickly and stay compliant before penalties increase. Available now through Amazon or Halfpricesoft.com…
Read More » -
Spinogenix Reports Early Improvements in Phase 2 Trial of Tazbentetol in Patients with Schizophrenia at the Schizophrenia International Research Society (SIRS) 2026 Annual Congress
First-in-Class Synaptic Regenerative Therapy Demonstrates Favorable Safety Profile and Early Potential to Improve Symptoms of Schizophrenia LOS ANGELES, March 26,…
Read More » -
Mercury13 Selects Catapult to Power Women-Specific Performance Models
The New Standard of Excellence Across all Clubs: Partnership will Build Custom Tech and Pioneer a New Era of Data-Driven…
Read More »







